Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

A Good Therapeutic Strategy to Unrecognized HIV Infection in A Patient with Multiple Myeloma Undergoing Peripheral Blood Stem Cell Transplantation - Case Report

Mehrdad Payandeh, Noorodin Karami*, Afshin Karami, Mehrnoush Aeinfar, Amir Yami, Sakineh Ghorbani, Roshanak Yousefi

Department of Genetics, Shahid Sadoughi University of Medical Science, Yazd, Iran

Abstract: Multiple myeloma is a hematological malignancy associated with increased plasma cell proliferation in the patient's bone marrow. HIV infection is an immunodeficiency disease that is present in some malignancies, such as non-Hodgkin's lymphomas, as an effective factor in the progression of malignancy. Our patient was diagnosed with multiple myeloma and after bone marrow transplantation, it became clear that the patient was HIV positive and also, he had a mild toxoplasmosis infection. After diagnosis, the patient was treated with antiviral drugs and drugs for the treatment of toxoplasma infection. After several months and carrying out the relevant tests, it indicates the control of HIV viral infection, and the patient is still being treated and followed up. Nonetheless, our case features the significance of HIV testing in early malignancy.

Keywords: multiple myeloma, malignancy, non-Hodgkin, lymphoma, transplantation, toxoplasmosis

Citation: Mehrdad Payandeh, Noorodin Karami, Afshin Karami, Mehrnoush Aeinfar, Amir Yami, Sakineh Ghorbani, Roshanak Yousefi, A Good Therapeutic Strategy to Unrecognized HIV Infection in A Patient with Multiple Myeloma Undergoing Peripheral Blood Stem Cell Transplantation - Case Report. American Journal of Cancer Prevention, 6 (1). 17-19. January 2018. doi:10.12691/ajcp-6-1-4

1. Introduction

Multiple myeloma is a malignancy of blood cells, which in its most important characteristic is the excessive proliferation of plasma cells [1]. The disease was first recognized by Samuel Sullen in 1844 [2]. Multiple myeloma represents 1% of all malignancies and 10-15% of hematological malignancies [3]. It occurs more often in adults, and the highest incidence of disease is Seventh decade [4,5]. When diagnosing this malignancy, several clinical and laboratory features are useful, including:

1. More than 10% of plasma cells are found in bone marrow.

2. Organ involvement, including cases of hypercalcemia and renal failure and bone lytic lesion

3. The presence of M protein in the patient's serum [6].

In HIV-infected patients, the most common hematologic malignancy is lymphoma. In spite of the fact that MM is uncommon in these patients, they have a higher risk than the all-inclusive community [7].

We report a patient with multiple myeloma witch had negative results from viral tests required before the transplant but after transplantation, he was referred to the hospital with a mild infection. By examining the viral tests, he was diagnosed HIV positive.

2. Case Presentation

A 43-year-old man referred to the Clinic of Hematology and oncology, Kermanshah, Iran in April 2016, and no clinical history was observed in the patient's medical records. The patient had symptoms such as bone pain, weakness and headache.

Initial investigations revealed normocytic, normochromic anemia with hemoglobin (Hb):8.4g/ dL, white blood count (WBC):1600/μL, platelet (Plt): 110 x 10³/μL. The result of the serum protein electrophoresis showed an increase in most protein bands is seen (see Table 1 for detailed analysis), especially in gamma band (Figure 1). Also, in his peripheral blood smear (PBS), anemia was observed rolouaex formation. The bone marrow aspiration (BMA) and bone marrow biopsy (BMB) were performed and it showed an increased percentage of plasma cells (12%) in bone marrow (Figure 2).

Table 1. Serum protein electrophoresis

Figure 1. Increase in most protein bands is seen, especially in gamma band

Figure 2. Photomicrograph of bone marrow aspiration showing plasma cell

Therefore, by interpreting the above results, his disease was diagnosed the multiple myeloma. Then, the patient was treated with chemotherapy drugs such as thalidomide 100 mg per day, dexamethasone 200 (Td) and bortezomib (velcade) 1.3 mg/day, cyclophosphamide 100 mg/day, and dexamethasone 200 mg/day (VCd), and Zometa (zoledronic acid) 400 mg/day. After 5 cycles of therapy with these drugs, the results of the complete blood count (CBC) were as follows:

WBC: 2.2 x 10³/μL, Hb: 10.6 g/dL and Plt: 180 x 10³/Μl.

These results indicate a relative improvement of the patient's condition and the readiness for autologous stem cell transplantation (ASCT). Then the patient was admitted to Imam Reza Hospital transplantation center in Kermanshah. Blood was tested for HIV-1 and 2 and for HBs Ag and Anti-HCV.The results of these tests before transplantation were completely negative, so the patient was transplanted.

The response to the treatment was complete and the plasma cell level was below 5%. The serum protein electrophoresis was normal (Figure 3 & Table 2). After 70 days of a successful transplant, the patient referred to the hospital for signs of weakness, anorexia, dry cough, and fever and chills. The results of the laboratory parameters revealed WBC: 0.2 x 10³/μL (lymphocyte: 15%), Hb: 6.6 g/dL, Plt: 29 x 10³/μL and ESR: 30 mm in 1st hr. Also, Serologic tests revealed a mild toxoplasma infection. By performing virus tests, unexpectedly the patient was diagnosed as HIV-positive with a viral load of >71,000 copies per ml. Also, absolute lymphocyte count (ALC) was 30 cells/μL and CD4 Lymphocyte Percentage was 3%.

Figure 3. Serum protein electrophoresis after transplantation

Table 2. Serum protein electrophoresis

Due to the patient's condition and the examination of his family members, it was revealed that his wife was HIV-infected, and the patient was a Carrier at the time of transplantation. At this time, the virus was in the window period, and it was not detectable in viral tests, and by reducing WBC and weakening the immune system in the post-transplant process, the virus comes out of the window period. At this time, the patient was treated with antiretroviral drugs such as Ziduvodin, Vonavir, effective in the treatment of HIV, and drugs such as fluconazole, azithromycin and pyrimethamine for the treatment of toxoplasmosis. After three months of this treatment, by performing a series of experiments such as CBC and lymphocyte markers, the results are as follows:

WBC: 2.7 x 10³/μL, Hb: 10g/dL, Plt: 65 x 10³μL and differential white blood cell count was contained 25% and absolute lymphocyte count (ALC): 675 cells/μL .His CD4 cell count was 27 cells/μL (4%). The above results indicate that the HIV infection is relatively well controlled and the patient is still under treatment and follow-up.

3. Discussion

About 6% of the immunodeficiency syndromes occur with lymphoma [8]. Multiple myeloma is a blood disorder characterized by the proliferation of monoclonal plasma cells [9] and this malignancy is very low in patients with HIV [10]. In previous studies, it has been proven that AIDS can progress and increase the risk of cancer [11]. HIV infection by mechanisms such as alters bone marrow niche microenvironment and increasing the risk of somatic hypermutation leads to the progression of multiple myeloma [6]. Our patient had some distinctive features: 1-In addition to multiple myeloma, he was also HIV positive. 2- Before the transplant, the patient was HIV-infected and the virus was also during the window period, so diagnostic tests could not be detected. 3-The multiple myeloma in the patient was as pancytopenia, which has a lower incidence [12]. 4-Using effective treatment methods such as highly active antiretroviral therapy (HAART) and combination chemotherapy, in addition to successful transplantation, HIV infection and toxoplasmosis were also controlled in the patient. There are two important factors that can't diagnose HIV infection in patients with multiple myeloma. The first factor is the HIV window period (4-12 weeks). The second factor is the similarity of some clinical and laboratory symptoms such as anemia, bacterial infection, pancytopenia, hypergammaglobulinemia, and bone marrow plasmacytosis, between HIV-positive patients with plasma cell malignancy and non-infected patients [12].

4. Conclusion

Our case illustrates the importance of HIV testing and family members' examination. Also, this article offers an appropriate approach for the transplantation of autologous stem cells in HIV positive patients, which can be promising.

References

[1]   | Noll, J.E., et al., Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells. Haematologica, 2014. 99(1): p. 163-171.
[2]   | Kyle, R.A. and D.P. Steensma, History of multiple myeloma, in Multiple Myeloma. 2011, Springer. p. 3-23.
[3]   | Raghavan, S.A., et al., Multiple myeloma of the jaw: A case report. Journal of Indian Academy of Oral Medicine and Radiology, 2014. 26(4): p. 454.
[4]   | Abdulsamad, M., et al., Immunoglobulin A Lambda Multiple Myeloma in a Patient with HIV: An Unusual Cause of Massive Ascites. Case reports in gastroenterology, 2017. 11(1): p. 201-206.
[5]   | Ishida, T. and H.D. Dorfman, Plasma cell myeloma in unusually young patients: a report of two cases and review of the literature. Skeletal radiology, 1995. 24(1): p. 47-51.
[6]   | Coker, W.J., et al., Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms. Biomarker research, 2013. 1(1): p. 8.
[7]   | Goedert, J.J., et al., Spectrum of AIDS-associated malignant disorders. The Lancet, 1998. 351(9119): p. 1833-1839.
[8]   | Fauci, A.S., Human immunodeficiency virus disease: AIDS and related disorders. Harrison's principles of internal medicine, 2005: p. 1076-1139.
[9]   | Stoopler, E.T., D.T. Vogl, and E.A. Stadtmauer, Medical management update: multiple myeloma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2007. 103(5): p. 599-609.
[10]   | Saif, M.W. and K. Shannon, Multiple myeloma and HIV infection: An association or a coincidence. JOURNAL OF APPLIED RESEARCH IN CLINICAL AND EXPERIMENTAL THERAPEUTICS, 2005. 5(2): p. 318.
[11]   | Levine, A.M., et al., Development of B-cell lymphoma in homosexual men. Ann Intern Med, 1984. 100(7).
[12]   | Patra, S.K., et al., A Rare Case of Multple Myeloma (Mm) Presented With Pancytopaenia in A Patient of HIV–At Very Early Age. Journal of clinical and diagnostic research: JCDR, 2015. 9(1): p. ED07.